| abstract |
This invention provides isolated nucleic acid molecules encoding a human dopamine D 1 receptor, isolated proteins which are human dopamine D 1 receptor, vectors comprising isolated nucleic acid molecules encoding a human dopamine D 1 receptor, mammalian cells comprising such vectors, antibodies directed to a human dopamine D 1 receptor, nucleic acid probes useful for detecting nucleic acid encoding human dopamine D 1 receptor, antisense oligonucleotides complementary to any sequences of a nucleic acid molecule which encodes a human dopamine D 1 receptor, pharmaceutical compounds related to human dopamine D 1 receptor, and nonhuman transgenic animals which express DNA a normal or a mutant human dopamine D 1 receptor. This invention further provides methods for determining ligand binding, detecting expression, drug screening, and treatment involving a human dopamine D 1 receptor. |